Merck sues to block Cancidas generic

11-08-2014

Merck sues to block Cancidas generic

Copyright © 2009-2014 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, N.J., U.S.A. All rights reserved.

New Jersey-based pharmaceutical company Merck has sued generic drug maker Fresenius for infringing patents relating to its anti-fungal injection Cancidas (caspofungin acetate).


Merck, Fresenius, Cancidas, District Court of Delaware, Hatch-Waxman Act

LSIPR